tenofovir alafenamide

Italy

Drugs containing this active substance

  • BIKTARVY

    Biktarvy is used for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults, adolescents, and children (aged 2 years and older and weighing at least 14 kg). The drug reduces the amount of HIV in the body, strengthens the immune system, and reduces the risk of illnesses related to the infection.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    bictegravir -
    tenofovir alafenamide -

    ATC: J05AR20

    Manufacturer: GILEAD SCIENCES IRELAND UC

  • DESCOVY

    It is used, in combination with other medicines, for the treatment of HIV-1 infection in adults and adolescents aged 12 years and older weighing at least 35 kg. The drug helps to reduce the amount of virus in the body.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir alafenamide -

    ATC: J05AR17

    Manufacturer: GILEAD SCIENCES IRELAND UC

  • EMTRICITABINE AND TENOFOVIR ALAFENAMIDE ZENTIVA

    This medicine is used, in combination with other medicines, for the treatment of HIV-1 infection in adults and adolescents aged 12 years and older weighing at least 35 kg.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir alafenamide -

    ATC: J05AR17

    Manufacturer: ZENTIVA ITALIA S.R.L.

  • EMTRICITABINE/RILPIVIRINE/TENOFOVIR ALAFENAMIDE VIATRI

    It is an antiviral drug used for the treatment of human immunodeficiency virus (HIV) infection in adults and adolescents aged 12 years and older weighing at least 35 kg. It is used to reduce the amount of HIV in the body, improving the immune system.

    Form: tablets, film-coated

    Active substance Dosage
    rilpivirine -
    tenofovir alafenamide -
    emtricitabine -

    ATC: J05AR19

    Manufacturer: VIATRIS LIMITED

  • EMTRICITABINE/TENOFOVIR ALAFENAMIDE VIATRI

    It is used in combination with other medicines for the treatment of HIV-1 infection in adults and adolescents aged 12 years and older weighing at least 35 kg. The drug helps to reduce the amount of virus in the body by blocking its multiplication.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    tenofovir alafenamide -

    ATC: J05AR17

    Manufacturer: VIATRIS LIMITED

  • ODEFSEY

    It is an antiviral drug used for the treatment of human immunodeficiency virus (HIV) infection in adults and adolescents aged 12 years and older weighing at least 35 kg. It serves to reduce the amount of virus in the body, improving the immune system.

    Form: tablets, film-coated

    Active substance Dosage
    emtricitabine -
    rilpivirine -
    tenofovir alafenamide -

    ATC: J05AR19

    Manufacturer: GILEAD SCIENCES IRELAND UC

  • SYMTUZA

    Symtuza is an antiretroviral medicine used for the treatment of HIV-1 infection in adults and adolescents aged 12 years and older weighing at least 40 kg. It helps to reduce the amount of HIV-1 in the body, improving immune defenses and reducing the risk of related illnesses, but it is not a cure for the infection.

    Form: tablets, film-coated

    Active substance Dosage
    darunavir -
    emtricitabine -
    cobicistat -
    tenofovir alafenamide -

    ATC: J05AR22

    Manufacturer: JANSSEN-CILAG INTERNATIONAL N.V.

  • VEMLIDY

    Vemlidy is used for the treatment of chronic hepatitis B in adults and children aged 6 years and older weighing at least 25 kg. The drug helps control the infection by preventing the virus from multiplying.

    Form: tablets, film-coated

    Active substance Dosage
    tenofovir alafenamide -

    ATC: J05AF13

    Manufacturer: GILEAD SCIENCES IRELAND UC